Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP)

Acta Microbiologica et Immunologica Hungarica

Volumn 61, Issue 2, 2014, Pages 161-172

  Szweda, Piotr ^a   Gucwa, Katarzyna ^a   Naumiuk, Lukasz ^b   Romanowska, Ewa ^c   Dzierzanowska Fangrat, Katarzyna ^c   Brillowska Dabrowska, Anna ^a   Wojciechowska Koszko, Iwona ^d   Milewski, Slawomir ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

C. glabrata; species identification tests; susceptibility testing

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; NYSTATIN; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA GLABRATA; CANDIDIASIS; DNA TEMPLATE; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; MICROBIOLOGY TEST; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; SPECIES IDENTIFICATION; YEAST;

C. GLABRATA; SPECIES IDENTIFICATION TESTS; SUSCEPTIBILITY TESTING;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDIASIS; FLUCONAZOLE; FLUCYTOSINE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84902801935     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.61.2014.2.6     Document Type: Article

References (21)

1. Arendrup, M.C.: Epidemiology of invasive candidiasis. Curr Opin Crit Care 16, 445-452 (2010).
2. Pfaller, M.A., Diekema, D.J.: Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36, 1-53 (2010).
3. Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., Edmond, M.B.: Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309-317 (2004).
4. Das, R.: An overview of changing trends in systemic fungal infections. WebmedCentral MICROBIOLOGY. 3:WMC003375 (2012).
5. Jabra-Rizk, M.A.: Fungal infections and drug resistance. Emergency Medicine & Critical Care Review 2, 38-41 (2006).
6. Dzierzanowska-Fangrat, K., Romanowska, E., Gryniewicz-Kwiatkowska, O., Migda, M., Witulska, K., Ryzko, J., Kalicinski, P., Ksiazyk, J., Nadkowska, P., Dzierzanowska, D.: Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010. Mycoses 8. doi: 10.1111/myc.12107 (2013)
7. Pfaller, M.A., Diekema, D.J., Sheehan, D.J.: Interpretive breakpoints for fluconazole and Candida revisited: A blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 19, 435-447 (2006).
8. Chen, Y., Eisner, J.D., Kattar, M.M., Rassoulian-Barret, S.L., Lafe, K., Bui, U., Limave, A.P., Cookson, B.T.: Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 39, 4042-4051 (2001).
9. Fujita, S., Seneda, Y., Nakaguchi, S., Hashimoto, T.: Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J Clin Microbiol 39, 3617-3622 (2001).
10. Luo, G., Mitchell, T.G.: Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol 40, 2860-2865 (2002).
11. Putignani, L., Del Chierico, F., Onori, M., Fiscarelli, E., Mancinelli, L., Ricciotti, G., Alghisi, F., Dimiziani, L., Manetti, C., Urbani, A., Muraca, M., Putignani, L.: MALDI-TOF mass spectrometry proteomic phenotyping of clinically relevant fungi. Mol Biosyst 7, 620-629 (2011).
12. Pulcrano, G., Iula, D.V., Vollaro, A., Tucci, A., Cerullo, M., Esposito, M., Rossano, F., Catania, M.R.: Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infections. J Microbiol Methods 94, 262-266 (2013).
13. Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard NCCLS document M27-A2. CLSI, Wayne, PA, 2002.
14. Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts: third edition (M27-A3). CLSI, Wayne, PA, 2008a.
15. Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts: Third informational supplement (M27-S3). CLSI, Wayne, PA, 2008b.
16. Olchawa, A., Krawczyk, B., Brillowska-Dabrowska, A.: New PCR test for detection of Candida glabrata based on the molecular target chosen by the RAPD technique. Pol J Microbiol 62, 81-84 (2013).
17. Torres-Rodriguez, J.M., Alvarado-Ramirez, E.: In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre Yeast One and standard CLSI (NCCLS) M27-A2 methods. J Antimicrob Chemother 60, 658-661 (2007).
18. Quindos, G., Sanchez-Vargas, L.O., Villar-Vidal, M., Eraso, E., Alkorta, M., Hernandez-Almaraz, J.L.: Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: A14-year study in a Spanish tertiary medical centre. Int J Antimicrob Agents 31, 266-271 (2008).
19. Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts: Fourth informational supplement (M27-S4). CLSI, Wayne, PA, 2008b.
20. Bicmen, C., Doluca, M., Gulat, S., Gunduz, A.T., Tuksavul, F.: Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus. New Microbiol 35, 327-334 (2012).
21. Morace, G., Amato, G., Bistoni, F., Fadda, G., Marone, P., Montagna, M.T., Oliveri, S., Polonelli, L., Rigoli, R., Mancuso, I., La Face, S., Masucci, L., Romano, L., Napoli, C., Tatò, D., Buscema, M.G., Belli, C.M., Piccirillo, M.M., Conti, S., Covan, S., Fanti, F., Cavanna, C., D'Alo, F., Pitzurra, L.: Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-A broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol 40, 2953-2958 (2002).